Growthlisted9999

Kaiyo Genomics Inc.

海洋ゲノミクス

Healthcare · Listed 2025-03-20

Price Overview

Offer Price

¥920

Range: ¥800–¥950

First Day Open

¥1,380

First Day Close

¥1,250

Current Price

¥1,250

Post-IPO Returns

1st Day

+50.0%

+42.4%

30d

+35.9%

90d

—

180d

—

52W High

¥1,420

52W Low

¥900

Avg Volume

4,500,000

Business Description

Kaiyo Genomics specializes in marine biodiversity genomics, developing novel drug candidates from deep-sea organisms. Their lead compound KG-401 targets treatment-resistant cancers using compounds derived from deep-sea sponges.

Risk Factors

Pre-revenue biotech with significant cash burn
Clinical trial failure risk for lead compound
Regulatory approval timeline uncertainty in both Japan and US markets

Offering Details

Lead UnderwriterSBI Securities

Bookbuilding2025-03-05 – 2025-03-11

Shares (Koubo)3,000,000

Shares (Uridashi)500,000

Overallotment500,000

Lock-up

Typeperiod

Period180 days